Androstenedione Market Report – Research, Industry Analysis Reports and Market Demands

Global Androstenedione Market Growth 2019-2024

Request for Sample of this report

Buy now

Table of Content

2019-2024 Global Androstenedione Consumption Market Report

1 Scope of the Report

2 Executive Summary

2.1 World Market Overview
- 2.1.1 Global Androstenedione Consumption 2014-2024
- 2.1.2 Androstenedione Consumption CAGR by Region
2.2 Androstenedione Segment by Type
- 2.2.1 4-AD
- 2.2.2 ADD
2.3 Androstenedione Consumption by Type
- 2.3.1 Global Androstenedione Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Androstenedione Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Androstenedione Sale Price by Type (2014-2019)
2.4 Androstenedione Segment by Application
- 2.4.1 Arthritis Pharmaceuticals
- 2.4.2 Fertility Control Pharmaceuticals
- 2.4.3 Infectious Inflammation Pharmaceuticals
- 2.4.4 Others
2.5 Androstenedione Consumption by Application
- 2.5.1 Global Androstenedione Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Androstenedione Value and Market Share by Application (2014-2019)
- 2.5.3 Global Androstenedione Sale Price by Application (2014-2019)

3 Global Androstenedione by Players

3.1 Global Androstenedione Sales Market Share by Players
- 3.1.1 Global Androstenedione Sales by Players (2017-2019)
- 3.1.2 Global Androstenedione Sales Market Share by Players (2017-2019)
3.2 Global Androstenedione Revenue Market Share by Players
- 3.2.1 Global Androstenedione Revenue by Players (2017-2019)
- 3.2.2 Global Androstenedione Revenue Market Share by Players (2017-2019)
3.3 Global Androstenedione Sale Price by Players
3.4 Global Androstenedione Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Androstenedione Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Androstenedione Products Offered
3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Androstenedione by Regions

4.1 Androstenedione by Regions
- 4.1.1 Global Androstenedione Consumption by Regions
- 4.1.2 Global Androstenedione Value by Regions
4.2 Americas Androstenedione Consumption Growth
4.3 APAC Androstenedione Consumption Growth
4.4 Europe Androstenedione Consumption Growth
4.5 Middle East & Africa Androstenedione Consumption Growth

5 Americas

5.1 Americas Androstenedione Consumption by Countries
- 5.1.1 Americas Androstenedione Consumption by Countries (2014-2019)
- 5.1.2 Americas Androstenedione Value by Countries (2014-2019)
5.2 Americas Androstenedione Consumption by Type
5.3 Americas Androstenedione Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Androstenedione Consumption by Countries
- 6.1.1 APAC Androstenedione Consumption by Countries (2014-2019)
- 6.1.2 APAC Androstenedione Value by Countries (2014-2019)
6.2 APAC Androstenedione Consumption by Type
6.3 APAC Androstenedione Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Androstenedione by Countries
- 7.1.1 Europe Androstenedione Consumption by Countries (2014-2019)
- 7.1.2 Europe Androstenedione Value by Countries (2014-2019)
7.2 Europe Androstenedione Consumption by Type
7.3 Europe Androstenedione Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Androstenedione by Countries
- 8.1.1 Middle East & Africa Androstenedione Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Androstenedione Value by Countries (2014-2019)
8.2 Middle East & Africa Androstenedione Consumption by Type
8.3 Middle East & Africa Androstenedione Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
10.2 Androstenedione Distributors
10.3 Androstenedione Customer

11 Global Androstenedione Market Forecast

11.1 Global Androstenedione Consumption Forecast (2019-2024)
11.2 Global Androstenedione Forecast by Regions
- 11.2.1 Global Androstenedione Forecast by Regions (2019-2024)
- 11.2.2 Global Androstenedione Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
11.7 Global Androstenedione Forecast by Type
11.8 Global Androstenedione Forecast by Application

12 Key Players Analysis

13 Research Findings and Conclusion

Description

Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) – an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone.
Androstenedione is used to evaluate the function of the adrenal gland and the ovaries or the testicles as well as the production of hormones related to the development of male sex organs and physical characteristics (androgens). It is most commonly used to determine the cause of symptoms of excess androgens in a woman who has an elevated testosterone level, along with a few other laboratory tests for this purpose.
Androstadienedione (1,4-androstadiene-3,17-dione) is an important industrial precursor for various steroid hormones. Androstadienedione is an important industrial-scale precursor for a wide variety of steroid hormones within the estrane and androstane classifications.

According to this study, over the next five years the Androstenedione market will register a 0.8% CAGR in terms of revenue, the global market size will reach US$ 200 million by 2024, from US$ 190 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Androstenedione business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Androstenedione market by product type, application, key manufacturers and key regions and countries.

This study considers the Androstenedione value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
4-AD
ADD
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Arthritis Pharmaceuticals
Fertility Control Pharmaceuticals
Infectious Inflammation Pharmaceuticals
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
BIOVET
Indo Phyto Chemicals
Sito Bio
Goto Pharmaceutical
Tianjin King York
Jiufu
Yongning Pharma
Jiangxi Hongyuan Pharmaceutical
Kaizon
Xi’an Gaoyuan Bio-Chem
Dongyao Pharmaceutical
Huazhong Pharmaceutical
Darui
Danjiangkou Danao
Dahua Pharmaceutical

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Androstenedione consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Androstenedione market by identifying its various subsegments.
Focuses on the key global Androstenedione manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Androstenedione with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Androstenedione submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.